Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Ultralow Dose PET Imaging of 18F-FDG Uptake

for
Healthy Volunteer, Cancer
Location: Englewood NJ
Sponsor: Akiva Mintz

Sex: All

Age: 18 - 70+

Code: NCT06956391

Phase 2, Recruiting

A Virtual Community Health Educator for Increasing Clinical Trial Referrals Among Cancer Patients and Their Caregivers

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT07126496

Recruiting

Lattice Radiation Therapy Versus Conventional Radiation Therapy for the Palliation of Large Tumors

for
Histopathologically or Cytologically Confirmed Solid Tumor Who Require Palliation Radiation Therapy to a Lesion ≥5cm,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18 - 70+

Code: NCT07444775

Phase 3, Recruiting

Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC

for
Metastatic Non-Squamous Non-Small Cell Lung Cancer,
Location: Mineola NY, New York NY, Durham NC, Birmingham AL,
Sponsor: CatalYm GmbH

Sex: All

Age: 18+

Code: NCT07246863

Phase 2, Recruiting

Navigation Interventions to Improve Cascade Genetic Testing Among Relatives of Patients With Hereditary Cancer Syndromes

for
Hereditary Malignant Neoplasm, Hereditary Neoplastic Syndrome
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 18+

Code: NCT06927947

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Implementing REmote SymPtom mOnitoring and maNagement (RESPONd)

for
Cancer
Location: Edmonton, Red Deer, Calgary
Sponsor: University of Calgary

Sex: All

Age: 18+

Code: NCT07024329

Recruiting

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

for
Cancer, Childhood Cancer,
Location: New Haven CT, Trumbull CT
Sponsor: Yale University

Sex: All

Age: 5+

Code: NCT07019259

Recruiting

A Study of BI 3810944 in Patients With Advanced Cancer

for
Solid Tumours, Melanoma
Location: Louisville KY, Nashville TN
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT07224425

Phase 1, Recruiting

Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL)

for
Leukemia, Relapsed Leukemia, Chronic Lymphocytic Leukemia,
Location: Boston MA
Sponsor: Jennifer R. Brown, MD, PhD

Sex: All

Age: 18+

Code: NCT06644183

Phase 1, Phase 2, Recruiting

A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

for
Malignant Neoplasm
Location: Sherbrooke, New York NY, Hackensack NJ, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06979596

Phase 2, Recruiting

Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer

for
NSCLC, Locally Advanced
Location: The Bronx NY
Sponsor: Montefiore Medical Center

Sex: All

Age: 18+

Code: NCT06865339

Phase 2, Recruiting

A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their Pain

for
Cancer Patients, Survivor Patients, Cancer Pain
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07447856

Phase 1, Recruiting

Clinical and Genetic Studies of Li-Fraumeni Syndrome

for
Li-Fraumeni Syndrome, Neoplasms, Tp53 Mutations
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT01443468

Recruiting

Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

for
Cardiovascular Diseases, Metabolic Syndrome, Obesity,
Location: Brooklyn NY
Sponsor: Clindove Research LLC

Sex: All

Age: 18+

Code: NCT07106879

Recruiting

Implementation of an Oral Chemotherapy Adherence Intervention

for
Solid Tumor, Hematologic Malignancy
Location: Chapel Hill NC
Sponsor: UNC Lineberger Comprehensive Cancer Center

Sex: All

Age: 21+

Code: NCT06989489

Recruiting

Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

for
Locally Advanced Pancreatic Adenocarcinoma
Location: Boston MA, Providence RI, Philadelphia PA,
Sponsor: EXACT Therapeutics AS

Sex: All

Age: 18+

Code: NCT06850623

Phase 2, Recruiting

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Raleigh NC, Tampa FL, Detroit MI, St Louis MO,
Sponsor: MOMA Therapeutics

Sex: All

Age: 18+

Code: NCT06974110

Phase 1, Recruiting

Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients

for
Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06807593

Phase 2, Recruiting

Enhancing the Patient Journey to Clinical Trial Enrolment With Navigation to Optimize Accrual

for
Cancer
Location: Windsor, Thunder Bay
Sponsor: Windsor Regional Hospital

Sex: All

Age: 0+

Code: NCT06905002

Recruiting

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

for
Sarcoma, Endocrine Tumors, Neuroblastoma, Retinoblastoma,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0+

Code: NCT01109394

Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial